.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Teva
Farmers Insurance
Julphar
Johnson and Johnson
Argus Health
AstraZeneca
Healthtrust
Citi
Colorcon

Generated: September 23, 2017

DrugPatentWatch Database Preview

Voriconazole - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for voriconazole and what is the scope of voriconazole freedom to operate?

Voriconazole
is the generic ingredient in two branded drugs marketed by Glenmark Pharms Ltd, Pf Prism Cv, Amneal Pharms, Aurobindo Pharma Ltd, Mylan Pharms Inc, Zydus Pharms Usa Inc, Akorn, Prinston Inc, Teva Pharms, Sandoz Inc, Xellia Pharms Aps, Appco Pharma Llc, Novel Labs Inc, Ajanta Pharma Ltd, and Alvogen Inc, and is included in twenty NDAs. There is one patent protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Voriconazole has fifty-seven patent family members in forty-six countries.

There are thirteen drug master file entries for voriconazole. Twenty-nine suppliers are listed for this compound.

Summary for Generic Name: voriconazole

Tradenames:2
Patents:1
Applicants:15
NDAs:20
Drug Master File Entries: see list13
Suppliers / Packagers: see list29
Bulk Api Vendors: see list62
Clinical Trials: see list115
Patent Applications: see list5,239
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:voriconazole at DailyMed

Pharmacology for Ingredient: voriconazole

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Appco Pharma Llc
VORICONAZOLE
voriconazole
TABLET;ORAL206762-002May 24, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Appco Pharma Llc
VORICONAZOLE
voriconazole
TABLET;ORAL206762-001May 24, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark Pharms Ltd
VORICONAZOLE
voriconazole
TABLET;ORAL203503-002Sep 2, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Ajanta Pharma Ltd
VORICONAZOLE
voriconazole
TABLET;ORAL206181-002May 24, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Pf Prism Cv
VFEND
voriconazole
TABLET;ORAL021266-002May 24, 2002ABRXYesYes► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
VORICONAZOLE
voriconazole
FOR SUSPENSION;ORAL202361-001May 28, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
VORICONAZOLE
voriconazole
TABLET;ORAL206837-001Jan 22, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
VORICONAZOLE
voriconazole
TABLET;ORAL206837-002Jan 22, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Prinston Inc
VORICONAZOLE
voriconazole
TABLET;ORAL206654-002Aug 8, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
VORICONAZOLE
voriconazole
TABLET;ORAL090547-002Apr 22, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: voriconazole

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pf Prism Cv
VFEND
voriconazole
TABLET;ORAL021266-002May 24, 2002► Subscribe► Subscribe
Pf Prism Cv
VFEND
voriconazole
INJECTABLE;IV (INFUSION)021267-001May 24, 2002► Subscribe► Subscribe
Pf Prism Cv
VFEND
voriconazole
TABLET;ORAL021266-002May 24, 2002► Subscribe► Subscribe
Pf Prism Cv
VFEND
voriconazole
INJECTABLE;IV (INFUSION)021267-001May 24, 2002► Subscribe► Subscribe
Pf Prism Cv
VFEND
voriconazole
FOR SUSPENSION;ORAL021630-001Dec 19, 2003► Subscribe► Subscribe
Pf Prism Cv
VFEND
voriconazole
TABLET;ORAL021266-001May 24, 2002► Subscribe► Subscribe
Pf Prism Cv
VFEND
voriconazole
FOR SUSPENSION;ORAL021630-001Dec 19, 2003► Subscribe► Subscribe
Pf Prism Cv
VFEND
voriconazole
INJECTABLE;IV (INFUSION)021267-001May 24, 2002► Subscribe► Subscribe
Pf Prism Cv
VFEND
voriconazole
FOR SUSPENSION;ORAL021630-001Dec 19, 2003► Subscribe► Subscribe
Pf Prism Cv
VFEND
voriconazole
INJECTABLE;IV (INFUSION)021267-001May 24, 2002► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: voriconazole

Country Document Number Estimated Expiration
Japan5089004► Subscribe
Slovakia282946► Subscribe
Japan2000513029► Subscribe
Slovenia1001813► Subscribe
Egypt23910► Subscribe
Israel132918► Subscribe
Bulgaria103882► Subscribe
Morocco26508► Subscribe
Algeria2523► Subscribe
Australia8110498► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: VORICONAZOLE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0030France► SubscribePRODUCT NAME: VORICONAZOLE; NAT. REGISTRATION NO/DATE: EU/1/02/212/001-025 20020319; FIRST REGISTRATION: EU/1/02/212/001-25 20020319
C/GB02/031United Kingdom► SubscribePRODUCT NAME: VORICONAZOLE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/02/212/001-025 20020319
2003005Lithuania► SubscribePRODUCT NAME: VORICONAZOLIS; REGISTRATION NO/DATE: 02/7890/8 20021002
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Baxter
Moodys
Fish and Richardson
Novartis
Cerilliant
Teva
Citi
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot